BACKGROUND: The population of people aged 90 years and older is expected to more than triple by 2050. The incidence of skin cancers is increasing. OBJECTIVE: We sought to determine whether treatment of patients aged 90 years and older with skin cancer by Mohs micrographic surgery (MMS) changed their survival. METHODS: A group of 214 patients aged 90 years and older who underwent MMS from July 1997 to May 2006 was identified. Patient gender, age, tumor type, size, site, defect size, number of MMS stages, and surgical repair were recorded. Comorbid medical conditions were assessed using the Charlson index. Actual survival was compared with expected length of survival using life tables. Data were analyzed by the Kaplan-Meier method with log rank significance tests. RESULTS: Average patient age was 92.3 years. All patients tolerated the procedures well with no deaths within 1 month after surgery. Median survival after surgery was 36.9 months. Tumor characteristics, defect size, number of surgical stages, and closure type did not affect survival. There was no significant difference in survival based on comorbidities according to Charlson scores. Instantaneous mortality hazard was highest 2 to 3 years after surgery. LIMITATIONS: Specific causes of death were not accessible. CONCLUSION: This growing section of the population may safely undergo MMS.
BACKGROUND: The population of people aged 90 years and older is expected to more than triple by 2050. The incidence of skin cancers is increasing. OBJECTIVE: We sought to determine whether treatment of patients aged 90 years and older with skin cancer by Mohs micrographic surgery (MMS) changed their survival. METHODS: A group of 214 patients aged 90 years and older who underwent MMS from July 1997 to May 2006 was identified. Patient gender, age, tumor type, size, site, defect size, number of MMS stages, and surgical repair were recorded. Comorbid medical conditions were assessed using the Charlson index. Actual survival was compared with expected length of survival using life tables. Data were analyzed by the Kaplan-Meier method with log rank significance tests. RESULTS: Average patient age was 92.3 years. All patients tolerated the procedures well with no deaths within 1 month after surgery. Median survival after surgery was 36.9 months. Tumor characteristics, defect size, number of surgical stages, and closure type did not affect survival. There was no significant difference in survival based on comorbidities according to Charlson scores. Instantaneous mortality hazard was highest 2 to 3 years after surgery. LIMITATIONS: Specific causes of death were not accessible. CONCLUSION: This growing section of the population may safely undergo MMS.
Authors: Karen L Connolly; Jiyeon M Jeong; Christopher A Barker; Marisol Hernandez; Erica H Lee Journal: J Am Acad Dermatol Date: 2017-02 Impact factor: 11.527
Authors: Niki B Vora; Karen L Connolly; Stephen Dusza; Anthony M Rossi; Kishwer S Nehal; Erica H Lee Journal: J Am Acad Dermatol Date: 2020-04-19 Impact factor: 11.527
Authors: Amanda Maisel-Campbell; Katherine A Lin; Sarah A Ibrahim; Bianca Y Kang; Noor Anvery; McKenzie A Dirr; Rachel E Christensen; Juliet L Aylward; Omar Bari; Hamza Bhatti; Diana Bolotin; Basil S Cherpelis; Joel L Cohen; Sean Condon; Sheila Farhang; Bahar Firoz; Algin B Garrett; Roy G Geronemus; Nicholas J Golda; Tatyana R Humphreys; Eva A Hurst; Oren H Jacobson; S Brian Jiang; Pritesh S Karia; Arash Kimyai-Asadi; David J Kouba; James G Lahti; Martha Laurin Council; Marilyn Le; Deborah F MacFarlane; Ian A Maher; Stanley J Miller; Eduardo K Moioli; Meghan Morrow; Julia Neckman; Timothy Pearson; Samuel R Peterson; Christine Poblete-Lopez; Chad L Prather; Jennifer S Ranario; Ashley G Rubin; Chrysalyne D Schmults; Andrew M Swanson; Christopher Urban; Y Gloria Xu; Murad Alam; Simon Yoo; Emily Poon; Vishnu Harikumar; Alexandra Weil; Sanjana Iyengar; Matthew R Schaeffer Journal: JAMA Dermatol Date: 2022-07-01 Impact factor: 11.816
Authors: Daniel A Hatef; William M Weathers; Erik M Wolfswinkel; Jayne E Coleman; James F Thornton Journal: Semin Plast Surg Date: 2013-05 Impact factor: 2.314
Authors: Emma M Rogers; Karen L Connolly; Kishwer S Nehal; Stephen W Dusza; Anthony M Rossi; Erica Lee Journal: J Am Acad Dermatol Date: 2017-12-27 Impact factor: 11.527
Authors: Marjolijn S Haisma; Linda Bras; Mehran Alizadeh Aghdam; Jorrit B Terra; Boudewijn E C Plaat; Emöke Rácz; Gyorgy B Halmos Journal: Acta Derm Venereol Date: 2020-06-18 Impact factor: 3.875
Authors: Erica H Lee; Rajiv I Nijhawan; Kishwer S Nehal; Stephen W Dusza; Amanda Levine; Amanda Hill; Christopher A Barker Journal: J Skin Cancer Date: 2015-06-09
Authors: A J G Leus; M Frie; M S Haisma; J B Terra; B E C Plaat; R J H M Steenbakkers; G B Halmos; E Rácz Journal: J Eur Acad Dermatol Venereol Date: 2020-03-30 Impact factor: 6.166